1. Home
  2. CECO vs VIR Comparison

CECO vs VIR Comparison

Compare CECO & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CECO Environmental Corp.

CECO

CECO Environmental Corp.

HOLD

Current Price

$60.43

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$5.90

Market Cap

825.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CECO
VIR
Founded
1966
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Pollution Control Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
825.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CECO
VIR
Price
$60.43
$5.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
11
Target Price
$59.50
$25.73
AVG Volume (30 Days)
301.8K
1.9M
Earning Date
10-28-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
334.15
N/A
EPS
1.43
N/A
Revenue
$718,253,000.00
$16,860,000.00
Revenue This Year
$39.58
N/A
Revenue Next Year
$14.60
$46.25
P/E Ratio
$42.02
N/A
Revenue Growth
29.86
N/A
52 Week Low
$17.57
$4.16
52 Week High
$63.98
$14.45

Technical Indicators

Market Signals
Indicator
CECO
VIR
Relative Strength Index (RSI) 58.96 45.75
Support Level $56.30 $5.76
Resistance Level $62.97 $6.12
Average True Range (ATR) 2.23 0.31
MACD -0.14 -0.07
Stochastic Oscillator 50.98 14.11

Price Performance

Historical Comparison
CECO
VIR

About CECO CECO Environmental Corp.

CECO Environmental Corp serves the energy, industrial, and other niche markets. The company operates through the Engineered Systems segment that serves the power generation, refinery, water/wastewater, and midstream oil and gas markets, and Industrial Process Solutions segment, which serves the broad industrial air pollution control, beverage can, fluid handling, electric vehicle production, food and beverage, semi-conductor, process filtration, pharmaceutical, petrochemical, wastewater treatment, wood manufacturing, desalination, and aquaculture markets. The majority of revenue is earned from the Engineered Systems Segment.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: